D.E. Shaw & Co
BHC icon

D.E. Shaw & Co’s Bausch Health BHC Stock Holding History

D.E. Shaw & Co’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-380,000
Closed -$3.04M – 4256
2023
Q2 		$3.04M Hold
380,000
– – ﹤0.01% 2289
2023
Q1 		$3.08M Buy
380,000
+304,000
+400% +$2.44M ﹤0.01% 2359
2022
Q4 		$477K Sell
76,000
-58,200
-43% -$406K ﹤0.01% 3878
2022
Q3 		$925K Hold
134,200
– – ﹤0.01% 3652
2022
Q2 		$1.12M Hold
134,200
– – ﹤0.01% 3559
2022
Q1 		$3.07M Buy
134,200
+100,000
+292% +$2.44M ﹤0.01% 2860
2021
Q4 		$944K Hold
34,200
– – ﹤0.01% 3977
2021
Q3 		$952K Hold
34,200
– – ﹤0.01% 3639
2021
Q2 		$1M Sell
34,200
-74,400
-69% -$2.25M ﹤0.01% 3536
2021
Q1 		$3.45M Buy
+108,600
New +$3.19M ﹤0.01% 2132
2020
Q4 		– Sell
-27,100
Closed -$421K – 3914
2020
Q3 		$421K Sell
27,100
-120,300
-82% -$2.07M ﹤0.01% 3302
2020
Q2 		$2.7M Sell
147,400
-72,600
-33% -$1.28M ﹤0.01% 2161
2020
Q1 		$3.41M Sell
220,000
-170,000
-44% -$4.1M 0.01% 1751
2019
Q4 		$11.7M Buy
390,000
+70,000
+22% +$1.82M 0.01% 1107
2019
Q3 		$6.99M Buy
320,000
+170,000
+113% +$3.89M 0.01% 1407
2019
Q2 		$3.78M Sell
150,000
-459,500
-75% -$10.9M ﹤0.01% 1797
2019
Q1 		$15.1M Sell
609,500
-435,500
-42% -$10.4M 0.02% 872
2018
Q4 		$19.3M Sell
1,045,000
-70,000
-6% -$1.67M 0.03% 732
2018
Q3 		$28.6M Sell
1,115,000
-53,500
-5% -$1.23M 0.03% 616
2018
Q2 		$27.2M Buy
1,168,500
+358,500
+44% +$7.41M 0.04% 579
2018
Q1 		$12.9M Sell
810,000
-148,400
-15% -$2.76M 0.02% 863
2017
Q4 		$19.9M Buy
958,400
+271,600
+40% +$4.31M 0.03% 687
2017
Q3 		$9.84M Sell
686,800
-8,500
-1% -$129K 0.02% 954
2017
Q2 		$12M Buy
695,300
+58,500
+9% +$701K 0.02% 809
2017
Q1 		$7.02M Sell
636,800
-2,397,600
-79% -$33M 0.01% 1067
2016
Q4 		$44.1M Sell
3,034,400
-1,509,500
-33% -$27.7M 0.07% 340
2016
Q3 		$112M Buy
4,543,900
+1,522,100
+50% +$39.4M 0.2% 105
2016
Q2 		$60.9M Buy
3,021,800
+334,900
+12% +$9.48M 0.11% 212
2016
Q1 		$70.7M Buy
2,686,900
+9,900
+0.4% +$732K 0.13% 185
2015
Q4 		$272M Buy
2,677,000
+2,655,400
+12,294% +$298M 0.41% 36
2015
Q3 		$3.85M Sell
21,600
-30,400
-58% -$7.09M 0.01% 1591
2015
Q2 		$11.6M Buy
52,000
+20,400
+65% +$4.52M 0.02% 936
2015
Q1 		$6.28M Sell
31,600
-20,000
-39% -$3.55M 0.01% 1236
2014
Q4 		$7.38M Buy
51,600
+40,000
+345% +$5.38M 0.01% 1296
2014
Q3 		$1.52M Sell
11,600
-60,000
-84% -$7.15M ﹤0.01% 2444
2014
Q2 		$9.03M Buy
71,600
+20,000
+39% +$2.55M 0.01% 1174
2014
Q1 		$6.8M Buy
51,600
+16,000
+45% +$2.19M 0.01% 1324
2013
Q4 		$4.18M Buy
35,600
+15,600
+78% +$1.71M 0.01% 1846
2013
Q3 		$2.09M Buy
+20,000
New +$1.95M ﹤0.01% 2379

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's BHC Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Bausch Health (BHC) stake by 63% in Q1 2026, selling an estimated $6.34M and leaving 621,755 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

D.E. Shaw & Co first reported a position in BHC in Q2 2013 and has held it in 48 quarters since. The position peaked at $614M in Q1 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • D.E. Shaw & Co held 621,755 shares of Bausch Health worth $3.36M as of Q1 2026.
  • D.E. Shaw & Co sold 1,058,874 Bausch Health shares in Q1 2026, an estimated $6.34M.
  • Bausch Health made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2490 holding.
  • D.E. Shaw & Co first reported a position in Bausch Health in Q2 2013 and has held it in 48 quarters since.
  • D.E. Shaw & Co's Bausch Health position peaked at $614M in Q1 2015.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.